Explore fresh findings using multimodal single-cell/nucleus genomics/epigenomics analytic approaches, along with interpretable deep learning and in silico network medicine, to uncover molecular networks between disease-associated microglia and astrocytes with implications for Alzheimer’s disease drug repurposing.